Dr. Frank Osborn, MD

NPI: 1083615942
Total Payments
$495.05
2024 Payments
$53.46
Companies
5
Transactions
9
Medicare Patients
9,747
Medicare Billing
$868,312

Payment Breakdown by Category

Education$411.55 (83.1%)
Food & Beverage$83.50 (16.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $411.55 4 83.1%
Food and Beverage $83.50 5 16.9%

Top Paying Companies

Company Total Records Latest Year
Coloplast Corp $411.55 4 $0 (2017)
Ardelyx, Inc. $35.89 2 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $18.46 1 $0 (2024)
Ipsen Biopharmaceuticals, Inc $15.62 1 $0 (2024)
Regeneron Healthcare Solutions, Inc. $13.53 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $53.46 3 Ardelyx, Inc. ($19.38)
2023 $30.04 2 Ardelyx, Inc. ($16.51)
2017 $411.55 4 Coloplast Corp ($411.55)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/06/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $18.46 General
Category: INTERNAL MEDICINE
06/25/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $15.62 General
Category: Rare Disease
05/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.38 General
Category: GASTROENTEROLOGY
09/26/2023 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $13.53 General
Category: INFLAMMATION AND IMMUNOLOGY
09/19/2023 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $16.51 General
Category: GASTROENTEROLOGY
10/06/2017 Coloplast Corp ALTIS (Device) Education Cash or cash equivalent $130.09 General
Category: FEMALE INCONTINENCE
06/08/2017 Coloplast Corp FEMALE INCONTINENCE (Device) Education Cash or cash equivalent $101.90 General
Category: FEMALE INCONTINENCE
04/21/2017 Coloplast Corp FEMALE INCONTINENCE (Device) Education Cash or cash equivalent $113.43 General
Category: FEMALE INCONTINENCE
02/01/2017 Coloplast Corp FEMALE INCONTINENCE (Device) Education Cash or cash equivalent $66.13 General
Category: FEMALE INCONTINENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 1,614 2,974 $644,762 $132,034
2022 5 2,500 4,453 $1.1M $224,304
2021 5 2,638 4,772 $1.2M $245,639
2020 5 2,995 5,404 $1.2M $266,336
Total Patients
9,747
Total Services
17,603
Medicare Billing
$868,312
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 1,212 2,520 $562,334 $101,988 18.1%
88312 Special stained specimen slides to identify organisms including interpretation and report Office 2023 258 280 $55,393 $21,215 38.3%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2023 116 126 $17,845 $6,540 36.6%
88341 Special stained specimen slides to examine tissue, each additional procedure Office 2023 11 28 $5,438 $1,301 23.9%
88342 Special stained specimen slides to examine tissue, initial procedure Office 2023 17 20 $3,752 $989.99 26.4%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2022 1,731 3,570 $885,020 $165,361 18.7%
88312 Special stained specimen slides to identify organisms including interpretation and report Office 2022 468 477 $104,940 $36,114 34.4%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2022 220 223 $32,739 $11,209 34.2%
88341 Special stained specimen slides to examine tissue, each additional procedure Office 2022 29 106 $25,150 $6,480 25.8%
88342 Special stained specimen slides to examine tissue, initial procedure Office 2022 52 77 $17,450 $5,141 29.5%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2021 1,785 3,824 $962,092 $180,305 18.7%
88312 Special stained specimen slides to identify organisms including interpretation and report Office 2021 577 593 $130,971 $44,592 34.0%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2021 211 213 $33,894 $11,610 34.3%
88341 Special stained specimen slides to examine tissue, each additional procedure Office 2021 28 104 $23,600 $6,385 27.1%
88342 Special stained specimen slides to examine tissue, initial procedure Office 2021 37 38 $8,900 $2,746 30.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2020 1,944 4,177 $998,509 $189,924 19.0%
88312 Special stained specimen slides to identify organisms including interpretation and report Office 2020 704 734 $148,080 $48,152 32.5%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2020 229 232 $35,331 $11,533 32.6%
88341 Special stained specimen slides to examine tissue Office 2020 50 179 $41,300 $11,082 26.8%
88342 Tissue or cell analysis by immunologic technique Office 2020 68 82 $18,700 $5,644 30.2%

About Dr. Frank Osborn, MD

Dr. Frank Osborn, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083615942.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Osborn, MD has received a total of $495.05 in payments from pharmaceutical and medical device companies, with $53.46 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Education" ($411.55).

As a Medicare-enrolled provider, Osborn has provided services to 9,747 Medicare beneficiaries, totaling 17,603 services with total Medicare billing of $868,312. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

Products in Payments

  • FEMALE INCONTINENCE (Device) $281.46
  • ALTIS (Device) $130.09
  • IBSRELA (Drug) $35.89
  • ENTYVIO (Biological) $18.46
  • IQIRVO (Drug) $15.62
  • DUPIXENT (Biological) $13.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Memphis